Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Congenital Heart Defects
|
0.300 |
Biomarker
|
group |
CTD_human |
Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.
|
1673020 |
1991 |
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.
|
1673020 |
1991 |
Lymphatic Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.
|
1673020 |
1991 |
Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
DiGeorge Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
Mouse and zebrafish Hoxa3 orthologues have nonequivalent in vivo protein function.
|
20498049 |
2010 |
DiGeorge Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
Hox group 3 paralogous genes act synergistically in the formation of somitic and neural crest-derived structures.
|
9441667 |
1997 |
DiGeorge Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.
|
1673020 |
1991 |
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Vital capacity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |
Hypertensive disease
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations.
|
28498854 |
2017 |
Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations.
|
28498854 |
2017 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations.
|
28498854 |
2017 |
Hypertensive disease
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.
|
27618448 |
2016 |
Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.
|
27618448 |
2016 |
Mean blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.
|
27618448 |
2016 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.
|
27618448 |
2016 |
Hypospadias
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analyses identify variants in developmental genes associated with hypospadias.
|
25108383 |
2014 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Mechanically, miR-10b targets HOXA3 to exert its tumor-suppressive effect on ccRCC in vitro.
|
30975094 |
2019 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
|
29073728 |
2018 |
Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
The purpose of this study was to determine whether the level of HOXA3, 7, 9, and 10 methylation in meningioma could be a biomarker linked to the pathologic characteristics of the tumor.
|
22735029 |
2012 |
Neoplasms
|
0.040 |
GeneticVariation
|
group |
BEFREE |
Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome.
|
21947269 |
2012 |
Malignant tumor of colon
|
0.020 |
Biomarker
|
disease |
BEFREE |
Recent studies have indicated that homeobox A3 (HOXA3) functions as a carcinogen in colon cancer and the methylation level of HOXA3 is significantly increased in lung adenocarcinoma (LUAD) tissues.
|
30066858 |
2018 |
Malignant tumor of colon
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
HOXA3 expression has been reported to be associated with several cancers; however, its role in colon cancer and underlying mechanism are still unclear.
|
29073728 |
2018 |